threo-4-Methylmethylphenidate (4-MeTMP) is a stimulant drug related to methylphenidate. It is slightly less potent than methylphenidate and has relatively low efficacy at blocking dopamine reuptake despite its high binding affinity which led to its investigation as a possible substitute drug for treatment of stimulant abuse (cf. nocaine).
This page contains content from the copyrighted Wikipedia article "4-Methylmethylphenidate"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
